Drug Profile
SEQ 400
Alternative Names: SEQ-400; Urinary tract infections vaccine - Sequoia Sciences; UTI vaccine - Sequoia SciencesLatest Information Update: 15 Sep 2023
Price :
$50
*
At a glance
- Originator Sequoia Sciences
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Urinary tract infections
Most Recent Events
- 15 Sep 2023 Phase-II clinical trials in Urinary tract infections (Recurrent, In adults) in USA (unspecified route)
- 08 Sep 2023 SEQ 400 is still in phase-I development in Urinary-tract-infections (Recurrent, In adults) in USA (Sequoia Sciences pipeline, September 2023)
- 08 Sep 2023 US FDA grants a compassionate use of FimH vaccine for Urinary-tract-infections, before September 2023 (Sequoia Sciences pipeline, September 2023)